Analysts expect Gossamer Bio, Inc. to report revenue of 10.41 M for Q3 26, against a range of 10.04 M to 10.79 M. The most recent reported quarter, Q2 26, came in at 9.24 M, a 143.0% beat against the 3.80 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 9.48 M | 9.38 M | 9.89 M | 11.49 M | 13.29 M | 13.80 M | 16.95 M | 9.24 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 9.18 M | 6.93 M | 4.70 M | 5.96 M | 7.11 M | 8.18 M | 4.83 M | 4.17 M | 10.79 M | 0.00 | 0.00 | 0.00 | 5.74 M | -2.01 M | 15.52 M | 15.91 M | ||||||||||
| Low Estimate | 8.34 M | 5.79 M | 3.86 M | 5.14 M | 6.34 M | 7.42 M | 4.14 M | 3.44 M | 10.04 M | 0.00 | 0.00 | 0.00 | 5.34 M | -2.38 M | 12.84 M | 14.21 M | ||||||||||
| Consensus Estimate | 8.76 M | 6.36 M | 4.28 M | 5.55 M | 6.72 M | 7.80 M | 4.49 M | 3.80 M | 10.41 M | 0.00 | 0.00 | 0.00 | 5.54 M | -2.19 M | 14.18 M | 15.06 M |
Analysts expect Gossamer Bio, Inc. to report earnings per share of -3.70 for Q3 26, against a range of -3.91 to -3.49. The most recent reported quarter, Q2 26, came in at -6.40, a 38.3% beat against the -10.38 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -11.20 | -12.00 | -12.80 | -13.60 | -16.80 | -16.80 | -16.00 | -6.40 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -10.93 | -12.82 | -14.81 | -12.11 | -15.12 | -14.03 | -11.31 | -10.06 | -3.49 | -3.58 | -3.77 | -3.86 | -2.58 | -2.03 | -2.85 | -2.15 | ||||||||||
| Low Estimate | -13.29 | -15.02 | -16.07 | -14.31 | -17.52 | -16.41 | -13.49 | -10.70 | -3.91 | -4.16 | -4.41 | -4.24 | -2.84 | -2.23 | -3.31 | -2.49 | ||||||||||
| Consensus Estimate | -12.11 | -13.92 | -15.44 | -13.21 | -16.32 | -15.22 | -12.40 | -10.38 | -3.70 | -3.87 | -4.09 | -4.05 | -2.71 | -2.13 | -3.08 | -2.32 |
Pull Wall Street consensus for Gossamer Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GOSS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GOSS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=GOSS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();